Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 12Leukemia 5Spondylitis, Ankylosing 3Psoriasis 3Myelodysplastic Syndromes 3Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Arthritis, Psoriatic 2Spondylarthritis 1Respiratory Distress Syndrome 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma 1Lung Neoplasms 1Lung Injury 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Inflammatory Bowel Diseases 1Infections 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Neoplasms 1HIV Infections 1Gulf War Illness 1

Interventions

Cyclophosphamide 3fludarabine phosphate 2Whole-Body Irradiation 2Vincristine 2Vaccines 2Rituximab 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Papillomavirus Vaccines 2Mass Screening 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Etoposide 2Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 2pandemrix 1lactitol 1halofantrine 1focetria 1fludarabine 1efineptakin alfa 1efavirenz 1X-Rays 1VAP-cyclo protocol 1Triage 1Transplantation Conditioning 1Tomography, X-Ray Computed 1Thiotepa 1Therapeutics 1Surveys and Questionnaires 1Standard of Care 1Spirometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × HIV Infections × Etanercept × Clear all
NCT00205231 2019-03-22

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

University of Wisconsin, Madison

Phase NA Completed
25 enrolled

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡